XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Common stock and Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ 168,919   $ 336,508 $ 25 $ (167,614)
Beginning Balance, Shares at Dec. 31, 2020   33,001,000      
Issuance of common stock, net of transaction costs, shares   4,562,000      
Issuance of common stock, net of transaction costs, value 72,558   72,558    
Stock issued under Stock Purchase Plan, shares   47,000      
Stock issued under Stock Purchase Plan, value 522   522    
Vesting of shares subject to repurchase 11   11    
Vesting of shares subject to repurchase, shares   8,000      
Exercise of stock options 802   802    
Exercise of stock options, shares   62,000      
Stock-based compensation 7,639   7,639    
Comprehensive loss (15)     (15)  
Net loss (48,996)       (48,996)
Ending Balance at Jun. 30, 2021 201,440   418,040 10 (216,610)
Ending Balance, Shares at Jun. 30, 2021   37,680,000      
Beginning Balance at Mar. 31, 2021 149,480   339,976 19 (190,515)
Beginning Balance, Shares at Mar. 31, 2021   33,017,000      
Issuance of common stock, net of transaction costs, shares   4,562,000      
Issuance of common stock, net of transaction costs, value 72,558   72,558    
Stock issued under Stock Purchase Plan, shares   47,000      
Stock issued under Stock Purchase Plan, value 522   522    
Vesting of shares subject to repurchase 6   6    
Vesting of shares subject to repurchase, shares   5,000      
Exercise of stock options 745   745    
Exercise of stock options, shares   49,000      
Stock-based compensation 4,233   4,233    
Comprehensive loss (9)     (9)  
Net loss (26,095)       (26,095)
Ending Balance at Jun. 30, 2021 201,440   418,040 10 (216,610)
Ending Balance, Shares at Jun. 30, 2021   37,680,000      
Beginning Balance at Dec. 31, 2021 331,944   607,581 (382) (275,255)
Beginning Balance, Shares at Dec. 31, 2021   47,597,000      
Issuance of common stock, net of transaction costs, shares   5,626,000      
Issuance of common stock, net of transaction costs, value 117,242   117,242    
Stock issued under Stock Purchase Plan, shares   66,000      
Stock issued under Stock Purchase Plan, value 813   813    
Vesting of shares subject to repurchase 2   2    
Vesting of shares subject to repurchase, shares   1,000      
Exercise of stock options $ 3,517   3,517    
Exercise of stock options, shares 429,955 430,000      
Stock-based compensation $ 12,886   12,886    
Comprehensive loss (3,237)     (3,237)  
Net loss (77,002)       (77,002)
Ending Balance at Jun. 30, 2022 386,165   742,041 (3,619) (352,257)
Ending Balance, Shares at Jun. 30, 2022   53,720,000      
Beginning Balance at Mar. 31, 2022 303,044   615,118 (2,192) (309,882)
Beginning Balance, Shares at Mar. 31, 2022   47,801,000      
Issuance of common stock, net of transaction costs, shares   5,626,000      
Issuance of common stock, net of transaction costs, value 117,242   117,242    
Stock issued under Stock Purchase Plan, shares   66,000      
Stock issued under Stock Purchase Plan, value 813   813    
Exercise of stock options 1,737   1,737    
Exercise of stock options, shares   227,000      
Stock-based compensation 7,131   7,131    
Comprehensive loss (1,427)     (1,427)  
Net loss (42,375)       (42,375)
Ending Balance at Jun. 30, 2022 $ 386,165   $ 742,041 $ (3,619) $ (352,257)
Ending Balance, Shares at Jun. 30, 2022   53,720,000